Release of soluble CD30 after allogeneic stimulation is mediated by memory t cells and regulated by IFN-γ and IL-2

Transplantation

Volumn 96, Issue 2, 2013, Pages 154-161

  Velásquez, Sonia Y ^a,b   García, Luis F ^a   Opelz, Gerhard ^b   Álvarez, Cristiam M ^a   Süsal, Caner ^b  

^a UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Allostimulation; CD30; IFN ; Memory T cells; sCD30

Indexed keywords

ADAM10 ENDOPEPTIDASE; CD30 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 2; NEUTRALIZING ANTIBODY; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME;

ADULT; ARTICLE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; KIDNEY FAILURE; MALE; MEMORY T LYMPHOCYTE; NORMAL HUMAN; PRIORITY JOURNAL; UPREGULATION;

ADAM PROTEINS; ADULT; AMYLOID PRECURSOR PROTEIN SECRETASES; ANTIGENS, CD30; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOLOGIC MEMORY; IMMUNOPHENOTYPING; INTERFERON-GAMMA; INTERLEUKIN-2; ISOANTIGENS; KIDNEY TRANSPLANTATION; LYMPHOCYTE ACTIVATION; MALE; MEMBRANE PROTEINS; MIDDLE AGED; SOLUBILITY; UP-REGULATION;

EID: 84880545874     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318296fd69     Document Type: Article

References (47)

1. Kalia V, Sarkar S, Gourley TS, et al. Differentiation of memory B and T cells. Curr Opin Immunol 2006; 18: 255.
2. Appay V, van Lier RA, Sallusto F, et al. Phenotype and function of human T lymphocyte subsets: consensus and issues. Cytometry A 2008; 73: 975.
3. Sallusto F, Geginat J, Lanzavecchia A. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol 2004; 22: 745.
4. Sallusto F, Lenig D, Forster R, et al. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999; 401: 708.
5. Romero P, Zippelius A, Kurth I, et al. Four functionally distinct populations of human effector-memory CD8+ T lymphocytes. J Immunol 2007; 178: 4112.
6. Okada R, Kondo T, Matsuki F, et al. Phenotypic classification of human CD4+ T cell subsets and their differentiation. Int Immunol 2008; 20: 1189.
7. Lecuroux C, Girault I, Urrutia A, et al. Identification of a particular HIV-specific CD8+ T-cell subset with a CD27+CD45RO-/RA+ phenotype and memory characteristics after initiation of HAART during acute primary HIV infection. Blood 2009; 113: 3209.
8. Ellis TM, Simms PE, Slivnick DJ, et al. CD30 is a signal-transducing molecule that defines a subset of human activated CD45RO+ T cells. J Immunol 1993; 151: 2380.
9. Romagnani S, Del Prete G, Maggi E, et al. CD30 and type 2 T helper (Th2) responses. J Leukoc Biol 1995; 57: 726.
10. Bengtsson A, Johansson C, Linder MT, et al. Not only Th2 cells but also Th1 and Th0 cells express CD30 after activation. J Leukoc Biol 1995; 58: 683.
11. Del Prete G, De Carli M, Almerigogna F, et al. Preferential expression of CD30 by human CD4+ T cells producing Th2-type cytokines. FASEB J 1995; 9: 81.
12. Eichenauer DA, Simhadri VL, von Strandmann EP, et al. ADAM10 inhibition of human CD30 shedding increases specificity of targeted immunotherapy in vitro. Cancer Res 2007; 67: 332.
13. Hansen HP, Dietrich S, Kisseleva T, et al. CD30 shedding from Karpas 299 lymphoma cells is mediated by TNF-alpha-converting enzyme. J Immunol 2000; 165: 6703.
14. Tarkowski M. Expression and a role of CD30 in regulation of T-cell activity. Curr Opin Hematol 2003; 10: 267.
15. Susal C, Pelzl S, Dohler B, et al. Identification of highly responsive kidney transplant recipients using pretransplant soluble CD30. J Am Soc Nephrol 2002; 13: 1650.
16. Pelzl S, Opelz G, Wiesel M, et al. Soluble CD30 as a predictor of kidney graft outcome. Transplantation 2002; 73: 3.
17. Rodriguez LM, Paris SC, Arbelaez M, et al. Kidney graft recipients with pretransplantation HLA class I antibodies and high soluble CD30 are at high risk for graft loss. Hum Immunol 2007; 68: 652.
18. Pelzl S, Opelz G, Daniel V, et al. Evaluation of posttransplantation soluble CD30 for diagnosis of acute renal allograft rejection. Transplantation 2003; 75: 421.
19. Susal C, Dohler B, Sadeghi M, et al. Posttransplant sCD30 as a predictor of kidney graft outcome. Transplantation 2011; 91: 1364.
20. Martinez OM, Villanueva J, Abtahi S, et al. CD30 expression identifies a functional alloreactive human T-lymphocyte subset. Transplantation 1998; 65: 1240.
21. Velasquez SY, Susal C, Opelz G, et al. Alloantigen-stimulated induction and release of CD30 in patients with end-stage renal failure. Hum Immunol 2012; 73: 1102.
22. Martinez OM. Immunobiology of CD30+ T lymphocytes. Graft 2001; 4: 8.
23. Chan KW, Hopke CD, Krams SM, et al. CD30 expression identifies the predominant proliferating T lymphocyte population in human alloimmune responses. J Immunol 2002; 169: 1784.
24. Ware CF. The TNF receptor super family in immune regulation. Immunol Rev 2011; 244: 5.
25. Josimovic-Alasevic O, Durkop H, Schwarting R, et al. Ki-1 (CD30) antigen is released by Ki-1-positive tumor cells in vitro and in vivo. I. Partial characterization of soluble Ki-1 antigen and detection of the antigen in cell culture supernatants and in serum by an enzymelinked immunosorbent assay. Eur J Immunol 1989; 19: 157.
26. Horie R, Watanabe T. CD30: expression and function in health and disease. Semin Immunol 1998; 10: 457.
27. Hargreaves PG, Al-Shamkhani A. Soluble CD30 binds to CD153 with high affinity and blocks transmembrane signaling by CD30. Eur J Immunol 2002; 32: 163.
28. Gerli R, Pitzalis C, Bistoni O, et al. CD30+ T cells in rheumatoid synovitis: mechanisms of recruitment and functional role. J Immunol 2000; 164: 4399.
29. Younes A, Consoli U, Snell V, et al. CD30 ligand in lymphoma patients with CD30+ tumors. J Clin Oncol 1997; 15: 3355.
30. Saini D, Ramachandran S, Nataraju A, et al. Activated effector and memory T cells contribute to circulating sCD30: potential marker for islet allograft rejection. Am J Transplant 2008; 8: 1798.
31. Taylor AL, Negus SL, Negus M, et al. Pathways of helper CD4 T cell allorecognition in generating alloantibody and CD8 T cell alloimmunity. Transplantation 2007; 83: 931.
32. Gilfillan MC, Noel PJ, Podack ER, et al. Expression of the costimulatory receptor CD30 is regulated by both CD28 and cytokines. J Immunol 1998; 160: 2180.
33. Heidt S, San Segundo D, Shankar S, et al. Peripheral blood sampling for the detection of allograft rejection: biomarker identification and validation. Transplantation 2011; 92: 1.
34. Bendjelloul F, Desin TS, Shoker AS. Donor non-specific IFN-gamma production by primed alloreactive cells as a potential screening test to predict the alloimmune response. Transpl Immunol 2004; 12: 167.
35. Reiss K, Saftig P. The ''a disintegrin and metalloprotease'' (ADAM) family of sheddases: physiological and cellular functions. Semin Cell Dev Biol 2009; 20: 126.
36. Huovila AP, Turner AJ, Pelto-Huikko M, et al. Shedding light on ADAM metalloproteinases. Trends Biochem Sci 2005; 30: 413.
37. Seals DF, Courtneidge SA. The ADAMs family of metalloproteases: multidomain proteins with multiple functions. Genes Dev 2003; 17: 7.
38. Pellegrini P, Berghella AM, Contasta I, et al. CD30 antigen: not a physiological marker for Th2 cells but an important costimulator molecule in the regulation of the balance between Th1/Th2 response. Transpl Immunol 2003; 12: 49.
39. Monsalve-De Castillo F, Romero TA, Estevez J, et al. Concentrations of cytokines, soluble interleukin-2 receptor, and soluble CD30 in sera of patients with hepatitis B virus infection during acute and convalescent phases. Clin Diagn Lab Immunol 2002; 9: 1372.
40. Kemp K, Kurtzhals JA, Akanmori BD, et al. Increased levels of soluble CD30 in plasma of patients with Plasmodium falciparum malaria. Clin Diagn Lab Immunol 2002; 9: 720.
41. Sercan O, Stoycheva D, Hammerling GJ, et al. IFN-gamma receptor signaling regulates memory CD8+ T cell differentiation. J Immunol 2010; 184: 2855.
42. Aune TM, Penix LA, Rincon MR, et al. Differential transcription directed by discrete gamma interferon promoter elements in naive and memory (effector) CD4 T cells and CD8 T cells. Mol Cell Biol 1997; 17: 199.
43. Ehlers S, Smith KA. Differentiation of T cell lymphokine gene expression: the in vitro acquisition of T cell memory. J Exp Med 1991; 173: 25.
44. Rifas L, Arackal S. T cells regulate the expression of matrix metalloproteinase in human osteoblasts via a dual mitogen-activated protein kinase mechanism. Arthritis Rheum 2003; 48: 993.
45. Kim MH, Kitson RP, Albertsson P, et al. Secreted and membraneassociated matrix metalloproteinases of IL-2-activated NK cells and their inhibitors. J Immunol 2000; 164: 5883.
46. Schroder K, Hertzog PJ, Ravasi T, et al. Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol 2004; 75: 163.
47. Boyman O, Sprent J. The role of interleukin-2 during homeostasis and activation of the immune system. Nat Rev Immunol 2012; 12: 180.